Clinical Trial

Clinical Study to Evaluate the Pharmacokinetics and Safety of CKD-339 in Healthy Volunteers

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study is a randomized, open-label, single dose, crossover study to evaluate the pharmacokinetics and safety of CKD-339 in healthy volunteers.
Trial Details
NCT Number NCT07748702
Lead Sponsor Chong Kun Dang Pharmaceutical
Conditions Hypertension
Enrollment 76 participants
Start Date 2026-08-20
Primary Completion 2026-10-06 (estimated)
Study Completion 2026-10-12 (estimated)
Updated on ClinicalTrials.gov 2026-08-06